On the public citation graph
Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model
0 signed · 91 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s12026-014-8534-zopenalex-snapshot
T cell-mediated immune response to respiratory coronaviruses
inferredcites →https://doi.org/10.1016/j.antiviral.2017.12.007openalex-snapshot
A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization
inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
inferredcites →https://doi.org/10.1016/j.cell.2020.06.010openalex-snapshot
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
inferredcites →https://doi.org/10.1016/j.cell.2020.06.043openalex-snapshot
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
inferredcites →https://doi.org/10.1016/j.cell.2020.08.017openalex-snapshot
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
inferredcites →https://doi.org/10.1016/j.clim.2006.05.002openalex-snapshot
Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients
inferredcites →https://doi.org/10.1016/j.coviro.2015.06.009openalex-snapshot
Animal models for SARS and MERS coronaviruses
inferredcites →https://doi.org/10.1016/j.immuni.2020.04.023openalex-snapshot
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
inferredcites →https://doi.org/10.1016/j.vaccine.2019.06.053openalex-snapshot
Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations
inferredcites →https://doi.org/10.1016/j.virusres.2007.03.025openalex-snapshot
Animal models and vaccines for SARS-CoV infection
inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
inferredcites →https://doi.org/10.1016/s0140-6736(20)30211-7openalex-snapshot
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
inferredcites →https://doi.org/10.1016/s0140-6736(20)30251-8openalex-snapshot
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
inferredcites →https://doi.org/10.1016/s2213-2600(20)30076-xopenalex-snapshot
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
inferredcites →https://doi.org/10.1038/d41573-020-00073-5openalex-snapshot
The COVID-19 vaccine development landscape
inferredcites →https://doi.org/10.1038/nrmicro2090openalex-snapshot
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
inferredcites →https://doi.org/10.1038/s41467-020-16505-0openalex-snapshot
Immunogenicity of a DNA vaccine candidate for COVID-19
inferredcites →https://doi.org/10.1038/s41586-020-2196-xopenalex-snapshot
Virological assessment of hospitalized patients with COVID-2019
inferredcites →https://doi.org/10.1038/s41586-020-2456-9openalex-snapshot
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
inferredcites →https://doi.org/10.1038/s41586-020-2550-zopenalex-snapshot
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
inferredcites →https://doi.org/10.1038/s41591-020-0965-6openalex-snapshot
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
inferredcites →https://doi.org/10.1101/2020.05.13.093195openalex-snapshot
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
inferredcites →https://doi.org/10.1101/2020.06.29.174888openalex-snapshot
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
inferredcites →https://doi.org/10.1126/sciadv.aba8399openalex-snapshot
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
inferredcites →https://doi.org/10.1126/science.abc1932openalex-snapshot
Development of an inactivated vaccine candidate for SARS-CoV-2
inferredcites →https://doi.org/10.1126/science.abc4776openalex-snapshot
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
inferredcites →https://doi.org/10.1126/science.abc6284openalex-snapshot
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
inferredcites →https://doi.org/10.1126/science.abc6952openalex-snapshot
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
inferredcites →https://doi.org/10.1126/scitranslmed.aac7462openalex-snapshot
A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
inferredcites →https://doi.org/10.1128/jvi.01505-14openalex-snapshot
Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
inferredcites →https://doi.org/10.1172/jci.insight.137079openalex-snapshot
Robust antibody and cellular responses induced by DNA-only vaccination for HIV
inferredcites →https://doi.org/10.15585/mmwr.mm6923e4openalex-snapshot
SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members — USS Theodore Roosevelt, April 2020
inferredcites →https://doi.org/10.2174/157016211797635928openalex-snapshot
Differential Innate Immune Responses to Low or High Dose Oral SIV Challenge in Rhesus Macaques
inferredcites →https://doi.org/10.3389/fphar.2020.00937openalex-snapshot
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
inferredcites →https://doi.org/10.4049/jimmunol.0903490openalex-snapshot
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/jmv.28484openalex-snapshot
Needle‐free injection system delivery of ZyCoV‐D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS‐CoV‐2
inferred← citeshttps://doi.org/10.1007/s11908-021-00752-3openalex-snapshot
Status Report on COVID-19 Vaccines Development
inferred← citeshttps://doi.org/10.1016/j.addr.2020.12.006openalex-snapshot
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
inferred← citeshttps://doi.org/10.1016/j.addr.2021.01.014openalex-snapshot
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
inferred← citeshttps://doi.org/10.1016/j.bbrc.2020.11.026openalex-snapshot
Functional importance of the D614G mutation in the SARS-CoV-2 spike protein
inferred← citeshttps://doi.org/10.1016/j.biologicals.2022.08.001openalex-snapshot
Molecular characterization and sequecing analysis of SARS-CoV-2 genome in Minas Gerais, Brazil
inferred← citeshttps://doi.org/10.1016/j.cell.2021.01.035openalex-snapshot
Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.1016/j.chom.2021.08.002openalex-snapshot
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
inferred← citeshttps://doi.org/10.1016/j.csbj.2020.12.039openalex-snapshot
Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
inferred← citeshttps://doi.org/10.1016/j.ebiom.2022.104264openalex-snapshot
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.108232openalex-snapshot
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
inferred← citeshttps://doi.org/10.1016/j.vaccine.2021.06.057openalex-snapshot
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model
inferred← citeshttps://doi.org/10.1016/j.vaccine.2022.03.060openalex-snapshot
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
inferred← citeshttps://doi.org/10.1038/s41467-021-21639-wopenalex-snapshot
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
inferred← citeshttps://doi.org/10.1038/s41541-021-00419-zopenalex-snapshot
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2
inferred← citeshttps://doi.org/10.1038/s42003-021-02443-0openalex-snapshot
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
inferred← citeshttps://doi.org/10.1074/jbc.ra120.016284openalex-snapshot
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
inferred← citeshttps://doi.org/10.1080/14760584.2022.2071264openalex-snapshot
Nonhuman primate models for evaluation of SARS-CoV-2 vaccines
inferred← citeshttps://doi.org/10.1093/infdis/jiaa784openalex-snapshot
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
inferred← citeshttps://doi.org/10.1101/2020.08.15.252437openalex-snapshot
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment immunogen
inferred← citeshttps://doi.org/10.1101/2021.01.05.422952openalex-snapshot
Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primates
inferred← citeshttps://doi.org/10.1101/2021.02.02.429480openalex-snapshot
Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1101/2021.05.07.21256652openalex-snapshot
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure
inferred← citeshttps://doi.org/10.1101/2021.06.29.21255526openalex-snapshot
Transmissibility of COVID-19 among Vaccinated Individuals: A Rapid Literature Review - Update #1
inferred← citeshttps://doi.org/10.1101/2021.10.05.461434openalex-snapshot
Immunogenicity of SARS-CoV-2 trimetric spike protein associated to Poly(I:C) plus Alum
inferred← citeshttps://doi.org/10.1126/sciadv.abe8065openalex-snapshot
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
inferred← citeshttps://doi.org/10.1126/sciadv.abf1591openalex-snapshot
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
inferred← citeshttps://doi.org/10.1126/science.abe2402openalex-snapshot
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
inferred← citeshttps://doi.org/10.1128/jcm.01533-20openalex-snapshot
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients
inferred← citeshttps://doi.org/10.1139/cjm-2020-0465openalex-snapshot
Frontrunners in the race to develop a SARS-CoV-2 vaccine
inferred← citeshttps://doi.org/10.1186/s12929-020-00695-2openalex-snapshot
Coronavirus vaccine development: from SARS and MERS to COVID-19
inferred← citeshttps://doi.org/10.1186/s40779-020-00296-yopenalex-snapshot
SARS-CoV-2: vaccines in the pandemic era
inferred← citeshttps://doi.org/10.12688/openreseurope.14375.1openalex-snapshot
Assessment of the efficacy of SARS-CoV-2 vaccines in non-human primate studies: a systematic review
inferred← citeshttps://doi.org/10.1371/journal.ppat.1009701openalex-snapshot
Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques
inferred← citeshttps://doi.org/10.1590/1678-4685-gmb-2020-0320openalex-snapshot
SARS-CoV-2 vaccine development and how Brazil is contributing
inferred← citeshttps://doi.org/10.21203/rs.3.rs-76768/v1openalex-snapshot
Immunogenicity and protective efficacy of BBV152: a whole virion inactivated SARS CoV-2 vaccine in the Syrian hamster model
inferred← citeshttps://doi.org/10.31219/osf.io/u3fwjopenalex-snapshot
Assessment of the efficacy of SARS-CoV-2 vaccines in non-human primate studies - a systematic review
inferred← citeshttps://doi.org/10.3389/fimmu.2020.583077openalex-snapshot
Emerging Concepts and Technologies in Vaccine Development
inferred← citeshttps://doi.org/10.3389/fmedt.2020.571030openalex-snapshot
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
inferred← citeshttps://doi.org/10.3389/fmicb.2022.789882openalex-snapshot
The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.3390/cells10020206openalex-snapshot
COVID-19: Characteristics and Therapeutics
inferred← citeshttps://doi.org/10.3390/ijerph19042392openalex-snapshot
Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants
inferred← citeshttps://doi.org/10.3390/jpm12030386openalex-snapshot
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm
inferred← citeshttps://doi.org/10.3390/v13030382openalex-snapshot
Multivalent DNA Vaccines as a Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses
inferred← citeshttps://doi.org/10.3390/v13081457openalex-snapshot
Human Coronaviruses: Counteracting the Damage by Storm
inferred← citeshttps://doi.org/10.3390/v13081673openalex-snapshot
The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues
inferred← citeshttps://doi.org/10.3390/vaccines8030534openalex-snapshot
Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
inferred← citeshttps://doi.org/10.3390/vaccines9080886openalex-snapshot
COVID-19 Research: Lessons from Non-Human Primate Models
inferred← citeshttps://doi.org/10.3390/vaccines9101082openalex-snapshot
COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects
inferred← citeshttps://doi.org/10.34172/apb.2022.045openalex-snapshot
Recent Update of COVID-19 Vaccines
inferred← citeshttps://doi.org/10.4103/ijmr.ijmr_4925_20openalex-snapshot
Heterogeneity in protocols for bronchoalveolar lavage & sub-genomic RNA evaluation in non-human primate studies of SARS-CoV-2 vaccine candidates’ evaluation
inferred← citeshttps://doi.org/10.4110/in.2021.21.e4openalex-snapshot
Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.